Safety of rotavirus vaccine in the NICU

Pediatrics

Volumn 133, Issue 6, 2014, Pages

  Monk, Heather M ^a   Motsney, Adam J ^a   Wade, Kelly C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Infant; Preterm infant; Rotavirus; Vaccine immunization

Indexed keywords

ROTAVIRUS VACCINE;

ABDOMINAL DISTENSION; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE TRANSMISSION; DRUG SAFETY; DRUG TOLERABILITY; FECES ANALYSIS; FEMALE; FEVER; GASTROENTERITIS; HOSPITAL READMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN INTENSIVE CARE; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; PSEUDOMONAS; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; ROTAVIRUS INFECTION; SEPSIS; STAPHYLOCOCCUS; VACCINATION; VOMITING;

INFANT; PRETERM INFANT; ROTAVIRUS; VACCINE/IMMUNIZATION;

DIARRHEA, INFANTILE; ENTERAL NUTRITION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; RETROSPECTIVE STUDIES; RISK FACTORS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINES, ATTENUATED;

EID: 84901823311     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-3504     Document Type: Article

References (26)

1. Payne DC, Wikswo M, Parashar UD. Rotavirus. In: Roush SW, McIntyre L, Baldy LM, eds. Manual for the Surveillance of Vaccine-Preventable Diseases. 5th ed. Atlanta, GA: Centers for Disease Control and Prevention, 2012;13-1-13-11
2. Dennehy PH, Cortese MM, Bégué RE, et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in US children. Pediatr Infect Dis J. 2006;25(12):1123-1131 (Pubitemid 44900675)
3. Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics. 1999;103(1). Available at: www.pediatrics.org/cgi/content/full/103/1/E3
4. Cortese MM, Parashar UD; Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1-25
5. Parashar UD, Alexander JP, Glass RI; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-12):1-13
6. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of rotavirus disease: guidelines for use of rotavirus vaccine. Pediatrics. 2007;119(1):171-182
7. Rotateq (rotavirus vaccine, live, oral, pentavalent) [package insert]. Whitehouse Station, NJ: Merck & Co, Inc; September 2010
8. Vesikari T, Clark HF, Offit PA, et al. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants. Vaccine. 2006;24(22):4821-4829 (Pubitemid 43776799)
9. Peter G, Myers MG; National Vaccine Advisory Committee; National Vaccine Program Office. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 2002;110(6). Available at: www.pediatrics.org/cgi/content/ full/110/6/e67
10. Committee on Infectious Diseases; American Academy of Pediatrics. Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine. Pediatrics. 2009;123(5):1412-1420
11. Anderson EJ. Rotavirus vaccines: viral shedding and risk of transmission. Lancet Infect Dis. 2008;8(10):642-649
12. Smith CK, McNeal MM, Meyer NR, Haase S, Dekker CL. Rotavirus shedding in premature infants following first immunization. Vaccine. 2011;29(45):8141-8146
13. Payne DC, Edwards KM, Bowen MD, et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics. 2010;125 (2). Available at: www.pediatrics.org/cgi/content/full/125/ 2/e438
14. Stumpf KA, Thompson T, Sánchez PJ. Rotavirus vaccination of very low birth weight infants at discharge from the NICU. Pediatrics. 2013;132(3). Available at: www.pediatrics.org/cgi/content/full/132/3/e662
15. Hsieh YC, Wu FT, Hsiung CA, Wu HS, Chang KY, Huang YC. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine. Vaccine. 2014;32(10):1199-1204
16. Dennehy PH, Goveia MG, Dallas MJ, Heaton PM. The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine. Int J Infect Dis. 2007;11(suppl 2):S36-S42 (Pubitemid 350298919)
17. Vesikari T, Karvonen A, Korhonen T, et al. Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants. Vaccine. 2004;22(21-22):2836-2842 (Pubitemid 38900662)
18. Phua KB, Quak SH, Lee BW, et al. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants. J Infect Dis. 2005;192(suppl 1):S6-S16 (Pubitemid 41193096)
19. Dennehy PH, Brady RC, Halperin SA, et al North American Human Rotavirus Vaccine Study Group. Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine. Pediatr Infect Dis J. 2005;24(6):481-488 (Pubitemid 40847519)
20. Rivera L, Peña LM, Stainier I, et al. Horizontal transmission of a human rotavirus vaccine strain - a randomized, placebo-controlled study in twins. Vaccine. 2011;29(51):9508-9513
21. Salinas B, Pérez Schael I, Linhares AC, et al. Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: A randomized, placebo-controlled trial in Latin American infants. Pediatr Infect Dis J. 2005;24(9):807-816 (Pubitemid 41324890)
22. Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, et al. Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants. Pediatrics. 2007;120(2). Available at: www.pediatrics.org/cgi/content/ full/120/2/e253
23. Bernstein DI, Sack DA, Rothstein E, et al. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial. Lancet. 1999;354(9175):287-290 (Pubitemid 29348737)
24. Ward RL, Kirkwood CD, Sander DS, et al. Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12. J Infect Dis. 2006;194(12):1729-1736 (Pubitemid 44902005)
25. Araujo EC, Clemens SA, Oliveira CS, et al. Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. J Pediatr (Rio J). 2007;83(3):217-224 (Pubitemid 46883821)
26. Australian Technical Advisory Group on Immunisation. The Australian Immunisation Handbook. 10th ed. Canberra, Australia: Australian Government Department of Health, 2013 (updated January 2014)